0001246360-13-003818.txt : 20130802 0001246360-13-003818.hdr.sgml : 20130802 20130802174917 ACCESSION NUMBER: 0001246360-13-003818 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130801 FILED AS OF DATE: 20130802 DATE AS OF CHANGE: 20130802 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ASPEN TECHNOLOGY INC /DE/ CENTRAL INDEX KEY: 0000929940 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371] IRS NUMBER: 042739697 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 200 WHEELER ROAD CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 6179491000 MAIL ADDRESS: STREET 1: 200 WHEELER ROAD CITY: BURLINGTON STATE: MA ZIP: 01803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCARDLE JOAN C CENTRAL INDEX KEY: 0001251386 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34630 FILM NUMBER: 131007561 4 1 form.xml PRIMARY DOCUMENT X0306 4 2013-08-01 false 0000929940 ASPEN TECHNOLOGY INC /DE/ AZPN 0001251386 MCARDLE JOAN C ASPEN TECHNOLOGY, INC. 200 WHEELER ROAD BURLINGTON MA 01803 true false false false Common Stock 60000 I By employer Common Stock 2013-08-01 4 A false 2727 0 A 22064 D Director Stock Option (Right to Buy) 32.54 2013-08-01 4 A false 3496 0 A 2023-07-31 Common Stock 3496 3496 D These securities are held by Massachusetts Capital Resource Company. The reporting person serves as a senior vice president of Massachusetts Capital Resource Company, and may be deemed to have shared voting power over these securities. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units were fully vested on the date of grant. Restricted Stock Units do not have an exercise price. The option granted at the exercise price of $32.54 was fully vested on the date of grant. /s/ F.G. Hammond, Attorney-In-Fact 2013-08-02